Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2005
60 patients with major depression will be treated with 10 mg Olanzapine or Placebo for 2 weeks. In case of response (reduction of depressive symptoms)the study will be continued for further 60 days.
Epistemonikos ID: a2f5852f436d20275852329a65696dc1ad29d8a1
First added on: May 04, 2024